This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Clanotech Ab. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2015
Title: The Innovative Contributions of Johan Wannberg
Introduction
Johan Wannberg is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Johan Wannberg holds two patents, with his latest focusing on quinoline derivatives and their use as tyrosine kinase inhibitors. The patent describes a compound of formula (I) along with pharmaceutically acceptable salts thereof. This compound is particularly useful for treating various medical conditions, including cancer, diabetic retinopathy, age-related macular degeneration, inflammation, stroke, ischemic myocardium, atherosclerosis, macular edema, and psoriasis.
Career Highlights
Johan is associated with Clanotech AB, where he applies his expertise in pharmaceutical innovation. His work has been instrumental in advancing therapeutic options for patients suffering from serious health conditions.
Collaborations
Johan collaborates with talented individuals such as Jacob Westman and Natalia Nekhotiaeva, contributing to a dynamic research environment that fosters innovation.
Conclusion
Johan Wannberg's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His patents and collaborations highlight his commitment to improving healthcare through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile